Lobbying client

PARTNER THERAPEUTICS

Biopharmaceutical company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 4 of its records are shown together here.

Filings
54
Filed by
4
Reported in-house
—
Reported by firms
$2,765,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2021 to 2026

Filings

54 filings, newest first.
Filing Filed by Amount
3rd Quarter - Amendment
3rd Quarter 2021
SL STRATEGIES, LLC $45,000 reported
3rd Quarter - Report
3rd Quarter 2021
THE MADISON GROUP $75,000 reported
Registration
3rd Quarter 2021
SL STRATEGIES, LLC — reported
Registration
3rd Quarter 2021
THE MADISON GROUP — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
PUTALASTRATEGIES 19 $1,110,000
SL STRATEGIES, LLC 21 $945,000
CGCN GROUP, LLC 7 $560,000
THE MADISON GROUP 3 $150,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 54
Budget/Appropriations BUD 21
Defense DEF 6

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
S. 3799 117th 4
H.R. 2471 117th 1
H.R. 2617 117th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.